This article details the improvements in the photosensitising ability of bimetallic N-carbazole complexes when compared to their mononuclear counterparts.
Four novel transition metal-carborane photosensitisers were prepared by Sonogashira cross-coupling of 1-(4-ethynylbenzyl)-2-methyl-o-carborane (A-CB) with halogenated Ru(II)- or Ir(III)-phenanthroline complexes. The resulting boron-rich complexes with one (RuCB and IrCB) or two carborane cages (RuCB2 and IrCB2) were spectroscopically characterised, and their photophysical properties investigated. RuCB displayed the most attractive photophysical properties in solution (λem 635 nm, τT 2.53 μs, and φp 20.4%). Nanosecond time-resolved transient absorption studies were used to explore the 3MLCT nature of the triplet excited states, and the highest singlet oxygen quantum yields (ΦΔ) were obtained for the mono-carborane-phenanthroline complexes (RuCB: 52% and IrCB: 25%). None of the complexes produce dark toxicity in SKBR-3 cells after incubation under photodynamic therapy (PDT) conditions. Remarkably, mono-carboranes RuCB and IrCB were the best internalised by the SKBR-3 cells, demonstrating the first examples of tris-bidentate transition metal-carborane complexes acting as triplet photosensitisers for PDT with a high photoactivity; RuCB or IrCB killed ∼50% of SKBR-3 cells at 10 μM after irradiation. Therefore, the high-boron content and the photoactive properties of these photosensitisers make them potential candidates as dual anti-cancer agents for PDT and Boron Neutron Capture Therapy (BNCT).
A series of new Ir(III) complexes incorporating 3-(2-benzothiazolyl)-7-(diethylamino)coumarin (coumarin 6) and ethynylpyrene (EP) functionalised 1,10-phenanthroline (phen) were developed. [Ir(III)(coumarin 6)2(3-EP-phen)](PF6) (Ir-3) proved to be the most promising material in triplet photosensitising applications. Highly absorbing at λ = 485 nm (ε = 1.31 × 105 M−1 cm−1), it exhibits high upconversion and singlet oxygen quantum yields (ΦUC = 27.5%, ΦΔ = 81.5%) and an exemplary upconversion capability (η = 3.60 × 106 M−1 cm−1).
Two novel porphyrin-core systems were prepared by Sonogashira cross-coupling of the terminal alkyne groups of meso-tetra(4-ethynylphenyl)porphyrin-Zn(II) (P-1) with halogenated Ru(II)- or Ir(III)-phenanthroline complexes. The resulting compounds (P-Ru and P-Ir) were spectroscopically characterised and their photophysical properties were investigated (λem 625, 665 nm; τT 339.6 μs (P-Ru) and λem 530, 612, 664 nm; τT 396.6 μs (P-Ir)). Nanosecond time-resolved transient absorption studies were used to explore the 3MLCT nature of the triplet excited states, and the singlet oxygen quantum yields were determined (ΦΔ 44.8 (P-Ru), 33.2 (P-Ir)%). The subcellular uptake of P-Ru and P-Ir and their application as photosensitisers (PS) in photodynamic therapy (PDT) were explored due to their solution photophysics and absence of dark toxicity. Upon irradiation (λexc = 620–630 nm; 10 min; 33 J cm−2), both P-Ru and P-Ir killed 90% of SKBR-3 cells at 1 μM. Notably P-Ru induced a 77% decrease in cell viability at only 0.25 μM.